166 related articles for article (PubMed ID: 3890587)
1. Alcohol withdrawal syndromes: clinical management with lofexidine.
Cushman P; Forbes R; Lerner W; Stewart M
Alcohol Clin Exp Res; 1985; 9(2):103-8. PubMed ID: 3890587
[TBL] [Abstract][Full Text] [Related]
2. Alcohol withdrawal syndrome: clinical and hormonal responses to alpha 2-adrenergic agonist treatment.
Cushman P; Sowers JR
Alcohol Clin Exp Res; 1989 Jun; 13(3):361-4. PubMed ID: 2568765
[TBL] [Abstract][Full Text] [Related]
3. A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide.
Keaney F; Strang J; Gossop M; Marshall EJ; Farrell M; Welch S; Hahn B; Gonzalez A
Alcohol Alcohol; 2001; 36(5):426-30. PubMed ID: 11524309
[TBL] [Abstract][Full Text] [Related]
4. A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.
Yu E; Miotto K; Akerele E; Montgomery A; Elkashef A; Walsh R; Montoya I; Fischman MW; Collins J; McSherry F; Boardman K; Davies DK; O'Brien CP; Ling W; Kleber H; Herman BH
Drug Alcohol Depend; 2008 Sep; 97(1-2):158-68. PubMed ID: 18508207
[TBL] [Abstract][Full Text] [Related]
5. A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal.
Gorodetzky CW; Walsh SL; Martin PR; Saxon AJ; Gullo KL; Biswas K
Drug Alcohol Depend; 2017 Jul; 176():79-88. PubMed ID: 28527421
[TBL] [Abstract][Full Text] [Related]
6. Clonidine versus chlordiazepoxide in acute alcohol withdrawal: a preliminary report.
Baumgartner GR
South Med J; 1988 Jan; 81(1):56-60. PubMed ID: 3276009
[TBL] [Abstract][Full Text] [Related]
7. Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal.
Lin SK; Strang J; Su LW; Tsai CJ; Hu WH
Drug Alcohol Depend; 1997 Nov; 48(2):127-33. PubMed ID: 9363412
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans.
Walsh SL; Strain EC; Bigelow GE
Addiction; 2003 Apr; 98(4):427-39. PubMed ID: 12653813
[TBL] [Abstract][Full Text] [Related]
9. Lofexidine in alcohol withdrawal states.
Brunning J; Mumford JP; Keaney FP
Alcohol Alcohol; 1986; 21(2):167-70. PubMed ID: 3741551
[TBL] [Abstract][Full Text] [Related]
10. Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore.
Guo S; Manning V; Yang Y; Koh PK; Chan E; de Souza NN; Assam PN; Sultana R; Wijesinghe R; Pangjaya J; Kandasami G; Cheok C; Lee KM; Wong KE
J Subst Abuse Treat; 2018 Aug; 91():1-11. PubMed ID: 29910009
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial.
Fishman M; Tirado C; Alam D; Gullo K; Clinch T; Gorodetzky CW;
J Addict Med; 2019; 13(3):169-176. PubMed ID: 30531234
[TBL] [Abstract][Full Text] [Related]
12. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.
Kahn A; Mumford JP; Rogers GA; Beckford H
Drug Alcohol Depend; 1997 Jan; 44(1):57-61. PubMed ID: 9031821
[TBL] [Abstract][Full Text] [Related]
13. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
Gish EC; Miller JL; Honey BL; Johnson PN
Ann Pharmacother; 2010 Feb; 44(2):343-51. PubMed ID: 20040696
[TBL] [Abstract][Full Text] [Related]
14. Alpha2-adrenergic agonists in opioid withdrawal.
Gowing LR; Farrell M; Ali RL; White JM
Addiction; 2002 Jan; 97(1):49-58. PubMed ID: 11895270
[TBL] [Abstract][Full Text] [Related]
15. Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: A systematic review.
Kuszmaul AK; Palmer EC; Frederick EK
J Am Pharm Assoc (2003); 2020; 60(1):145-152. PubMed ID: 31791720
[TBL] [Abstract][Full Text] [Related]
16. Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome.
Baumgartner GR; Rowen RC
Arch Intern Med; 1987 Jul; 147(7):1223-6. PubMed ID: 3300587
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal and oral clonidine as prophylaxis for postoperative alcohol withdrawal syndrome: a randomized double-blinded study.
Dobrydnjov I; Axelsson K; Berggren L; Samarütel J; Holmström B
Anesth Analg; 2004 Mar; 98(3):738-44, table of contents. PubMed ID: 14980929
[TBL] [Abstract][Full Text] [Related]
18. [Use of clonidine in the prevention of alcohol withdrawal syndrome].
Mondavio M; Ghiazza GF
Minerva Med; 1989 Nov; 80(11):1233-5. PubMed ID: 2689915
[TBL] [Abstract][Full Text] [Related]
19. Investigation of clonidine and lofexidine for the treatment of barbiturate withdrawal in mice.
Siegel EG; Bonfiglio JF; Ritschel WA; Fant W
Vet Hum Toxicol; 1985 Dec; 27(6):503-5. PubMed ID: 4082462
[TBL] [Abstract][Full Text] [Related]
20. Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.
Strang J; Bearn J; Gossop M
Am J Addict; 1999; 8(4):337-48. PubMed ID: 10598217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]